Posted on 11 月 22, 202211/22/22
Ready or Not, Biosimilar Adalimumab Brings the Heat in 2023
Posted on 11 月 13, 202211/13/22
Establishing the Patient Access Mission During Clinical Development
Posted on 11 月 10, 202211/10/22
Regulatory Framework for Digital Therapeutics in the APAC Region
Posted on 11 月 3, 202211/3/22
Emerging Trends in the APAC MedTech Market
Posted on 10 月 17, 202210/17/22
Developing Best-in-class Copay Programs for Gross-to-Net
Posted on 10 月 12, 202210/12/22
The Evolution of HTA and Its Impact on Drug Prices in Japan
Posted on 9 月 2, 20229/2/22
Plasma derived medicinal products – What is the way forward?
Posted on 8 月 31, 20228/31/22
Single-Cell Multiomics: Opportunities, Challenges, and the Evolving Business Model
Posted on 8 月 30, 20228/30/22